EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intestinal Oxalate Absorption, Enteric Hyperoxaluria, and Risk of Urinary Stone Formation in Patients with Crohn’s Disease

Roswitha Siener, Charlotte Ernsten, Jan Speller, Christian Scheurlen, Tilman Sauerbruch iD, Albrecht Hesse

Nutrients · 2024

DOI: 10.3390/nu16020264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Roswitha Siener und 5 weiteren Autor:innen. Beteiligte Einrichtung: University Stone Center, Department of Urology, University Hospital Bonn, 53127 Bonn, Germany. Hauptthemen laut MEDLINE: Crohn Disease, Urinary Calculi, Urolithiasis, Hyperoxaluria. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nephrolithiasis is a common urologic manifestation of Crohn’s disease. The purpose of this study was to investigate the clinical characteristics, intestinal oxalate absorption, and risk factors for urinary stone formation in these patients. In total, 27 patients with Crohn’s disease and 27 healthy subjects were included in the present study. Anthropometric, clinical, and 24 h urinary parameters were determined, and the [13C2]oxalate absorption test was performed. Among all patients, 18 had undergone ileal resection, 9 of whom had a history of urinary stones. Compared to healthy controls, the urinary excretion values of calcium, magnesium, potassium, sulfate, creatinine, and citrate were significantly lower in patients with Crohn’s disease. Intestinal oxalate absorption, the fractional and 24 h urinary oxalate excretion, and the risk of calcium oxalate stone formation were significantly higher in patients with urolithiasis than in patients without urolithiasis or in healthy controls. Regardless of the group, between 83% and 96% of the [13C2]oxalate was detected in the urine within the first 12 h after ingestion. The length of ileum resection correlated significantly with the intestinal absorption and urinary excretion of oxalate. These findings suggest that enteric hyperoxaluria can be attributed to the hyperabsorption of oxalate following extensive ileal resection. Oral supplementation of calcium and magnesium, as well as alkali citrate therapy, should be considered as treatment options for urolithiasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseUrinary CalculiUrolithiasisHyperoxaluriaHumansOxalatesCalciumMagnesiumCalcium, DietaryCitratesCitric Acid

Stichwörter der Autor:innen

Crohn’s diseasebowel resectioncalciumdietfat malabsorptionintestinal oxalate absorptionkidney stonesoxalatesecondary hyperoxaluriaurolithiasis

Substanzen

OxalatesCalciumMagnesiumCalcium, DietaryCitratesCitric Acid

Autor:innen und Institutionen

  • University Stone Center, Department of Urology, University Hospital Bonn, 53127 Bonn, Germany.
  • Department of Medical Biometry, Informatics and Epidemiology, Medical Faculty, University of Bonn, 53127 Bonn, Germany.
  • Department of Internal Medicine I, University Hospital Bonn, 53127 Bonn, Germany.

ORCID-Profile: Tilman Sauerbruch

Zitieren

APA

Siener, R., Ernsten, C., Speller, J., Scheurlen, C., Sauerbruch, T., & Hesse, A. (2024). Intestinal Oxalate Absorption, Enteric Hyperoxaluria, and Risk of Urinary Stone Formation in Patients with Crohn’s Disease. Nutrients. https://doi.org/10.3390/nu16020264

Vancouver

Siener R, Ernsten C, Speller J, Scheurlen C, Sauerbruch T, Hesse A. Intestinal Oxalate Absorption, Enteric Hyperoxaluria, and Risk of Urinary Stone Formation in Patients with Crohn’s Disease. Nutrients. 2024. doi:10.3390/nu16020264

BibTeX
@article{Siener2024,
  author = {Siener, Roswitha and Ernsten, Charlotte and Speller, Jan and Scheurlen, Christian and Sauerbruch, Tilman and Hesse, Albrecht},
  title = {Intestinal Oxalate Absorption, Enteric Hyperoxaluria, and Risk of Urinary Stone Formation in Patients with Crohn’s Disease},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16020264}
}
Kostenlos starten →